Zydus Cadila gets USFDA nod for diabetes medication

    0
    zydus cadila, diabetes medication


    zydus cadila, diabetes medication
    Image Source : PTI/REPRESENTATIONAL

    Zydus Cadila gets USFDA nod for diabetes medication

    Drug firm Zydus Cadila on Monday said it has received approval from the US health regulator to market Sitagliptin, a medicine indicated to treat diabetes. The company said its subsidiary has received tentative approval from the United States Food and Drug Administration (FDA) for its new drug application for Sitagliptin base 25, 50 and 100 mg tablets.

    On October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100 mg tablets.

    The NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.

    Zydus Cadila discovers, develops, manufactures, and markets a broad range of healthcare therapies including small molecule drugs, biologic therapeutics, and vaccines.

    The group employs around 23,000 people worldwide.

    Also Read: Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD

    Also Read: ‘ZyCoV-D’ vaccine 66% efficient against Covid Delta variant: Zydus Group MD

    Latest Business News





    Source link

    See also  Fuel Rate Today: Petrol, diesel price cut by 15 paise per litre after a week's break | Check revised rate